Bone Marrow Mesenchymal Stem Cell (BM-MSC) Release Microvesicles/Exosomes That Incorporate Into Hematopoietic Cells From MDS Patients and May Modify Their.

Slides:



Advertisements
Similar presentations
Stem cell concepts renew cancer research by John E. Dick Blood Volume 112(13): December 15, 2008 ©2008 by American Society of Hematology.
Advertisements

A Score Based on IPSS-R, Ferritin and EPO Levels Predicts Erythroid Response to ESAs and Survival in Lower Risk Anemic MDS Patients with High Probability.
Phenotypic and Functional Changes Induced at the Clonal Level in Hematopoietic Stem Cells After 5-Fluorouracil Treatment by Troy D. Randall, and Irving.
Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow by Cesare Campagnoli, Irene A. G. Roberts,
by Paul A. Carpenter, Meei-Li Huang, and George B. McDonald
Volume 17, Issue 6, Pages (June 2009)
Sequential Third-Party Mesenchymal Stromal Cell Therapy for Refractory Acute Graft- versus-Host Disease  Fermín Sánchez-Guijo, Teresa Caballero-Velázquez,
The influence of high-altitude living on body iron
The Prognostic Value Of Dynamic Monitoring C-Reactive Protein (CRP) Serum Levels In NK/T-Cell Lymphoma by Bing Bai, Qi-chun Cai, Xiao-Xiao Wang, Qingqing.
Do HSCs divide asymmetrically?
Comparable results of umbilical cord blood and HLA-matched sibling donor hematopoietic stem cell transplantation after reduced-intensity preparative regimen.
Neoplastic blood cells become pluripotent
Second Allogeneic Hematopoietic Cell Transplantation in Patients with Hematologic Malignancies for Relapse After First Allografts by Boglarka Gyurkocza,
by Roel Polak, Bob de Rooij, Rob Pieters, and Monique L. den Boer
by Zhenping Zhu Blood Volume 108(6): September 15, 2006
Successful Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplant in an Acute Leukemia Patient With Chemotherapy-Induced Marrow Aplasia and Progressive.
by Alexis S. Bailey, Shuguang Jiang, Michael Afentoulis, Christina I
The Hematopoietic Stem Cell Transplant Comorbidity Index (HCT-CI) Can Predict for Readmission Following Autologous Stem Cell Transplant for Lymphoma and.
by Satish Gopal, William A. Wood, Stephanie J. Lee, Thomas C
Mutagenic potential of temozolomide in bone marrow cells in vivo
Fusion genes in cord blood
Functional neutrophils from human ES cells
Long-term follow-up of allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning for patients with chronic myeloid leukemia.
Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets.
In Utero Depletion Of Fetal Host Hematopoietic Stem Cells Improves Engraftment Following Neonatal Transplantation In Mice by Chris Derderian, Charmin King,
Immunomodulatory effect of 5-azacytidine (5-azaC): potential role in the transplantation setting by Luis I. Sánchez-Abarca, Silvia Gutierrez-Cosio, Carlos.
Blood Volume 92(10): November 15, 1998
by Jayesh Mehta Blood Volume 112(2): July 15, 2008
by Thomas B. Russell, Amy M. Skinner, and Peter Kurre
by Douglas D. Ross, Judith E. Karp, Tar T. Chen, and L. Austin Doyle
Prognostic Factors of Chronic Graft-versus-Host Disease Following Allogeneic Peripheral Blood Stem Cell Transplantation: The National Institutes Health.
ROCK and Rho(ll) in bone marrow
by Paul A. Carpenter, Meei-Li Huang, and George B. McDonald
Stem-cell trafficking at vascular borders
Insulin content of isolated pancreas and islet morphology.
TIE2hi/VEGFAhi TEMs are present in the TMEM
by John J. Strouse, Megan E. Reller, David G
Low Dose Thymoglobulin Results In Improved Outcomes After Allogeneic Unrelated Hematopoietic Stem Cell Transplantation (HCT) For Patients With Acute Myeloid.
Cytokine-Release Syndrome in Patients With B-Cell Chronic Lymphocytic Leukemia and High Lymphocyte Counts After Treatment With an Anti-CD20 Monoclonal.
Characterizing Donor-Derived Cells in Nonhematopoietic Tissue
Detection of bone marrow–derived lung epithelial cells
The IMS fuses to the plasma membrane at the protrusion tip.
Timing and Utility of Relapse Surveillance after Allogeneic Hematopoietic Cell Transplantation in Children with Leukemia  Anya Levinson, Staci Arnold,
Feasibility and Outcome of Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant High-Dose Cyclophosphamide for Children and Adolescents.
Immunohistochemical analysis.
GFP positive cells detected under confocal microscope
Fig. 7. NPs accumulate at sites of vascular obstruction.
Proplatelets and large protrusions are morphologically distinct and possess different MT arrangements. Proplatelets and large protrusions are morphologically.
Successful hematopoietic stem cell mobilization and apheresis collection using plerixafor alone in sickle cell patients by Erica B. Esrick, John P. Manis,
Inhibition of VEGFA or macrophage-specific ablation of Vegfa from TIE2hi/VEGFAhi TMEM macrophages reduces vascular permeability and tumor cell intravasation.
Sequential Third-Party Mesenchymal Stromal Cell Therapy for Refractory Acute Graft- versus-Host Disease  Fermín Sánchez-Guijo, Teresa Caballero-Velázquez,
Immunohistochemical analysis of individual StanEx enhancer trap line expression in larval brain and VNC. Third larval instar CNS and VNC expression of.
Systemic Toxoplasmosis Post Allogeneic Stem Cell Transplantation (Allo-SCT): Lessons Learned from HIV?  Marie von Lilienfeld-Toal, MD, Maria Gilleece,
ILK knockdown decreases mTOR signaling in PKD kidneys.
Hematopoietic potential of HEP from patient-specific iPSC may be reduced. Hematopoietic potential of HEP from patient-specific iPSC may be reduced. (A)
740. Prevention of Radiation-Induced Lung Injury by Administration of Gene-Modified Mesenchymal Stem Cells    Molecular Therapy  Volume 20, Pages S285-S286.
Bridge to transplant following Bv+Bs regimen.
Pancreatic β-cell proliferation.
Exo70 is recruited to the plasma membrane at sites of mechanical wounding. Exo70 is recruited to the plasma membrane at sites of mechanical wounding. NRK.
Monitoring Mixed Lineage Leukemia Expression May Help Identify Patients with Mixed Lineage Leukemia–Rearranged Acute Leukemia Who Are at High Risk of.
CENP-F staining in prometaphase and metaphase spermatocytes from B6 and Rb/+ mice. CENP-F staining in prometaphase and metaphase spermatocytes from B6.
Pain. Pain. (A) Skeletal pain experienced by bone marrow (BM) and peripheral blood stem cell (PBSC) donors at baseline, during the pericollection period,
TP53 Mutations in AML Predict Adverse Outcome in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant by Bartlomiej M Getta, Arnab Ghosh,
Mary Eapen  Biology of Blood and Marrow Transplantation 
Mesenchymal Stem Cell-Derived Vesicles Reverse Hematopoietic Radiation Damage by Sicheng Wen, Laura R Goldberg, Mark S Dooner, John L Reagan, and Peter.
Fig. 1 Deficient CD73 and CD39 expressions and extracellular adenosine concentration in BM of OVX animals. Deficient CD73 and CD39 expressions and extracellular.
Pure red cell aplasia by Robert T. Means Blood
Critical Analysis on the Mechanism of Action (MoA) of the Anti-CD38 Monoclonal Antibody Isatuximab in Multiple Myeloma (MM)‏ by Laura Moreno, Aintzane.
SY-1425 induces maturation in RARA-high AML
by Victor A. Chow, Mazyar Shadman, and Ajay K. Gopal
Presentation transcript:

Bone Marrow Mesenchymal Stem Cell (BM-MSC) Release Microvesicles/Exosomes That Incorporate Into Hematopoietic Cells From MDS Patients and May Modify Their Behaviour by Sandra Muntión, Post Doc Fellowship, Teresa Ramos, Bruno Paiva, Beatriz Roson, Maria Eugenia Sarasquete, Maria Diez-Campelo, Maria Teresa Rejas, Marcos González, Jesus F San Miguel, and Maria-Consuelo del Cañizo Blood Volume 122(21):863-863 November 15, 2013 ©2013 by American Society of Hematology

MVs from MSC -MDS analysed by TEM. A. MVs from MSC -MDS analysed by TEM. A. Scale bar 500nm. B. Scale bar 200nm Sandra Muntión et al. Blood 2013;122:863 ©2013 by American Society of Hematology

CM images A- C Sequential images of CD34+ cells with MVs from MSC-MDS. CM images A- C Sequential images of CD34+ cells with MVs from MSC-MDS. A. overlay (CD90 in red and CD45 in green), B CD34+ with anti CD 90 (red) and C with anti-CD45 (green). DAPI (blue)‏ Sandra Muntión et al. Blood 2013;122:863 ©2013 by American Society of Hematology